However, TT genotype in ERCC2 Lys751Gln polymorphism may significantly decrease the risk of glioma in the Caucasian population with combined OR of 0.87 (0.78–0.97), but not in the Chinese population. The gene discussed is ERCC2; the disease is central nervous system cancer.